ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1823

Inflammation Is Associated with Erosive Progression in Patients with Hand Osteoarthritis: A Prospective Ultrasonography Study

Marion C. Kortekaas1,2, Wing Yee Kwok3, Monique Reijnierse4, Theo Stijnen5 and Margreet Kloppenburg6, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Flevoziekenhuis, Almere-Stad, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Medical Statistics, Leiden University Medical Center, Leiden, Netherlands, 6Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Inflammation, longitudinal studies and ultrasound, OA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Imaging in Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Erosive hand osteoarthritis (OA) is a subset that shows inflammatory features with ultrasound or MRI much more frequent than non-erosive hand OA, and can progress relatively fast. Whether inflammatory features are associated with erosive progression is unknown. Therefore, we investigated relationships between inflammatory ultrasound features and erosive progression over 2.3 years follow-up in hand OA patients.

Methods

In 56 consecutive hand OA patients (mean age 61 years, 86% female), recruited from the rheumatology outpatient clinic and all fulfilling ACR criteria, effusion, synovial thickening and Power Doppler signal (PDS) were assessed in all interphalangeal joints (IPJs) with ultrasound using standardized methods at baseline and after 2.3 years. Radiographs were scored at both time-points for osteophytes and joint space narrowing using the OARSI method and for erosive disease, defined as E(rosive)- and R(emodelled)-phase, using the Verbruggen-Veys method. Progression was defined as a non-erosive joint becoming erosive, or E-phase becoming R-phase. R-phases at baseline were excluded. Associations were analysed using GEE logistic regression, adjusting for age, gender, BMI and baseline structural abnormalities.

Results

At baseline 51 IPJs (18 patients) and at follow-up 100 IPJs (26 patients) were erosive, hence 49 IPJs showed erosive progression. Moderate/severe synovial thickening and PDS at baseline were associated with erosive progression: adjusted odds ratio (95% confidence interval) 6.3 (2.3-17.5) and 6.9 (2.0-23.3), respectively. Effusion showed a trend: 2.7 (0.94-7.7). Persistent inflammation, defined as inflammation present both at baseline and follow-up, showed stronger associations with erosive progression compared to inflammation present either at baseline or follow-up.

Conclusion

Inflammatory ultrasound features, especially when persistent, are associated with erosive progression in hand OA, implicating that inflammation plays a role in its pathogenesis and could be a therapeutic target.


Disclosure:

M. C. Kortekaas,
None;

W. Y. Kwok,
None;

M. Reijnierse,
None;

T. Stijnen,
None;

M. Kloppenburg,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammation-is-associated-with-erosive-progression-in-patients-with-hand-osteoarthritis-a-prospective-ultrasonography-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology